Medtech Startup Prodancy Bags INR 2.14 Cr Funding for Expansion

Existing investors, including the Center for Cellular & Molecular Platforms (C-CAMP) and other angel investors, also participated.

Prodancy, a Medtech startup specializing in surgical consumables for joint replacement surgeries, has raised INR 2.14 Cr in a funding round co-led by Campus Angels Network and Keiretsu Forum Chennai.

Existing investors, including the Center for Cellular & Molecular Platforms (C-CAMP) and other angel investors, also participated.

“These funds will expedite our product development and regulatory efforts, including FDA 510(k) approvals,” said Pradeep Vamana, Co-Founder of Prodancy.

According to him, the funding will support Prodancy’s growth in India and its expansion into global markets, including the United States.

India’s joint replacement surgery market is growing at a 22% compound annual growth rate (CAGR), and Prodancy aims to leverage this opportunity with its offerings.

The startup’s flagship product, Vizbl, is described as the world’s lightest surgical helmet, being 40% lighter and 50% more cost-effective than competitors. The no-chin-bar design enhances comfort and protection for surgeons, particularly during lengthy joint replacement procedures.

Since its launch in early 2023, over 230 Vizbl helmets have been sold, contributing to more than 12,000 surgeries across India’s top hospitals.

Co-founded by Vamana and Venkatesh Parthasarathy, Prodancy focuses on affordability and innovation in surgical consumables. The company is now scaling operations and preparing to meet international regulatory standards to enter global markets.

"We are grateful to our investors for supporting our vision,” said Vamana, acknowledging contributors from Keiretsu Chennai & Singapore and angel investors who played pivotal roles in the funding process.

Stay tuned for more such updates on Digital Health News.